Abstract PS06-09: Fragmentomic analysis of a circulating tumor DNA targeted cancer gene panel discriminates ER status in metastatic breast cancer liquid biopsies
Kyle T. Helzer(University of Wisconsin–Madison), Marina N. Sharifi(University of Wisconsin–Madison), Kari B. Wisinski(University of Wisconsin Carbone Cancer Center), Yue Shi(University of Wisconsin–Madison), Ruth O’Regan(University of Wisconsin Carbone Cancer Center), Mark E. Burkard(University of Wisconsin–Madison), Jamie M. Sperger(University of Wisconsin–Madison), Matthew L. Bootsma(University of Wisconsin–Madison), Shuang G. Zhao(University of Wisconsin Carbone Cancer Center), Malinda West(Oregon Health & Science University), Katherine R. Kaufmann(University of Wisconsin–Madison), Leilani Mora-Rodriguez(University of Wisconsin–Madison), Joshua M. Lang(University of Wisconsin–Madison), V. Carreño(University of Wisconsin–Madison), Hannah Krause(University of Wisconsin–Madison)
Cited by 0
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors
|Proceedings of the National Academy of Sciences|2003|650
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592